Stocktoria
Raphael Pharmaceutical Inc. RAPH
OTC · OOTC · stock
Raphael Pharmaceutical Inc. (RAPH) earns a Piotroski F-score of 3/9 (weak financial health). It does not currently pay a dividend.
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
FAQ
Is RAPH financially healthy?
Raphael Pharmaceutical Inc.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak).
Does RAPH pay a dividend?
No, Raphael Pharmaceutical Inc. does not currently pay a dividend.
Source: SEC EDGAR filings · CIK 0001415397 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.